Variant report

Variant	nsv1025841
Chromosome Location	chr6:162609719-162841434
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:22)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:22 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:162820265..162823089-chr6:162827852..162829559,2	K562	blood:
2	chr6:162666890..162668464-chr6:162670216..162671922,2	K562	blood:
3	chr6:162620407..162622935-chr6:162623040..162625617,2	K562	blood:
4	chr6:162661286..162663139-chr6:162673530..162675376,2	K562	blood:
5	chr6:162661286..162663139-chr6:162673530..162675376,2	K562	blood:
6	chr6:162763017..162765353-chr6:162767098..162769301,2	K562	blood:
7	chr6:162613600..162615384-chr6:162617227..162618872,2	K562	blood:
8	chr6:162643217..162645721-chr6:162646719..162648950,2	K562	blood:
9	chr6:162763017..162765353-chr6:162767098..162769301,2	K562	blood:
10	chr6:162666890..162668464-chr6:162670216..162671922,2	K562	blood:
11	chr6:162613600..162615384-chr6:162617227..162618872,2	K562	blood:
12	chr6:162768506..162770213-chr6:162786241..162788330,2	K562	blood:
13	chr6:162671180..162673472-chr6:162808694..162811227,2	K562	blood:
14	chr6:162721411..162723925-chr6:162726328..162729326,2	K562	blood:
15	chr6:162768506..162770213-chr6:162786241..162788330,2	K562	blood:
16	chr6:162721411..162723925-chr6:162726328..162729326,2	K562	blood:
17	chr6:162799485..162803733-chr6:162804296..162807777,5	K562	blood:
18	chr6:162820265..162823089-chr6:162827852..162829559,2	K562	blood:
19	chr6:162643217..162645721-chr6:162646719..162648950,2	K562	blood:
20	chr6:162799485..162803733-chr6:162804296..162807777,5	K562	blood:
21	chr6:162620407..162622935-chr6:162623040..162625617,2	K562	blood:
22	chr6:162671180..162673472-chr6:162808694..162811227,2	K562	blood:

No data

Extended variants
information (count: 9722 )
Associated
traits (count: 106 )

Variant overlapped rSNPs/rCNVs (count:9722 , 50 per page) page: 1 2 3 4 5 6 7 ... 195

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs9295184	chr6:162609719-162609720	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs139889317	chr6:162609731-162609732	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs200793133	chr6:162609736-162609737	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs571108308	chr6:162609741-162609742	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs537045484	chr6:162609762-162609763	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs141378955	chr6:162609763-162609764	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs573663756	chr6:162609779-162609780	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs571859207	chr6:162609786-162609787	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs535064081	chr6:162609809-162609810	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs201351596	chr6:162609810-162609811	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs571943780	chr6:162609815-162609816	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs542871876	chr6:162609817-162609818	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs398066462	chr6:162609826-162609827	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs397974757	chr6:162609827-162609828	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs553175280	chr6:162609888-162609889	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs114851267	chr6:162609914-162609915	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs545277631	chr6:162609962-162609963	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs542420401	chr6:162609964-162609965	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs565177085	chr6:162609969-162609970	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs551413827	chr6:162609974-162609975	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs181370252	chr6:162610019-162610020	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs574106918	chr6:162610025-162610026	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs543786688	chr6:162610027-162610028	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs563661109	chr6:162610040-162610041	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs186899452	chr6:162610058-162610059	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs143700593	chr6:162610125-162610126	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs377039208	chr6:162610135-162610136	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs528762144	chr6:162610143-162610144	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs554533022	chr6:162610152-162610153	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs190581360	chr6:162610153-162610154	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs571898902	chr6:162610162-162610163	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs369665323	chr6:162610166-162610167	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs536680794	chr6:162610184-162610185	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs182918883	chr6:162610193-162610194	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs377575810	chr6:162610224-162610225	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs202015337	chr6:162610246-162610247	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs370066812	chr6:162610250-162610251	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs186509956	chr6:162610252-162610253	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs200507988	chr6:162610278-162610279	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs553207920	chr6:162610282-162610283	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs573122443	chr6:162610287-162610288	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs530977853	chr6:162610298-162610299	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs190851324	chr6:162610317-162610318	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs11961127	chr6:162610330-162610331	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs543476237	chr6:162610347-162610348	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs182613748	chr6:162610348-162610349	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs567791814	chr6:162610362-162610363	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs12173327	chr6:162610383-162610384	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs542662189	chr6:162610397-162610398	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs150757510	chr6:162610414-162610415	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:106)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Renal cell carcinoma	18592004	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Developmental delay	21147756	CNVD
Chordoma	18071362	CNVD
Myelofibrosis	22110671	CNVD
Autism	22241247	CNVD
Breast cancer	16397240	CNVD
Atherosclerosis	21956041	CNVD
Maculopathy	20981449	CNVD
Retinoblastoma	22278416	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian cancer	20844748	CNVD
Uveal melanoma	20484589	CNVD
Glioblastoma multiforme	19435819	CNVD
Astrocytoma	16205629	CNVD
Parkinson disease	17160897	CNVD
Cancer	20164920	CNVD
Breast cancer	22522925	CNVD
Schizophrenia	20838587	CNVD
Early-onset parkinson disease	21993715	CNVD
Glioblastoma	18772890	CNVD
Pancreatic cancer	20981101	CNVD
Autism	21360662	CNVD
Melanoma	20877625	CNVD
Pancreatic cancer	17952125	CNVD
Intellectual disability	22102821	CNVD
Parkinson disease	0	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Parkinson disease	21829596	CNVD
Gastric cancer	22315472	CNVD
Schizophrenia	20967226	CNVD
Schizophrenia	21346763	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Attention deficit hyperactivity disorder	19546859	CNVD
Autism	22495309	CNVD
Glioblastoma multiforme	21138945	CNVD
Ovarian cancer	22355333	CNVD
Schizophrenia	19805367	CNVD
Bipolar disorder	19114987	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD

Chromatin state (count:734 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:162605800-162624200	Weak transcription	Pancreas	Pancrea
2	chr6:162606200-162609800	Enhancers	Fetal Heart	heart
3	chr6:162609600-162612000	Weak transcription	Right Atrium	heart
4	chr6:162609600-162622000	Weak transcription	Left Ventricle	heart
5	chr6:162609600-162622400	Weak transcription	Psoas Muscle	Psoas
6	chr6:162609800-162610800	Weak transcription	Fetal Heart	heart
7	chr6:162610800-162611000	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
8	chr6:162610800-162612400	Enhancers	Fetal Heart	heart
9	chr6:162612000-162613000	Enhancers	Right Atrium	heart
10	chr6:162612400-162615800	Weak transcription	Fetal Heart	heart
11	chr6:162613000-162621600	Weak transcription	Spleen	Spleen
12	chr6:162613000-162622000	Weak transcription	Right Atrium	heart
13	chr6:162615800-162617200	Enhancers	Fetal Heart	heart
14	chr6:162616200-162616400	Weak transcription	Aorta	Aorta
15	chr6:162616200-162617200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
16	chr6:162617200-162621800	Weak transcription	Fetal Heart	heart
17	chr6:162618800-162619200	Enhancers	iPS-18 Cell Line	embryonic stem cell
18	chr6:162619000-162619400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
19	chr6:162619000-162619400	Enhancers	HUES6 Cell Line	embryonic stem cell
20	chr6:162619200-162622000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
21	chr6:162619800-162620000	Enhancers	HUES6 Cell Line	embryonic stem cell
22	chr6:162620600-162620800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
23	chr6:162620800-162621400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
24	chr6:162620800-162623000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
25	chr6:162620800-162623000	Enhancers	Adipose Nuclei	Adipose
26	chr6:162621000-162622800	Enhancers	Skeletal Muscle Female	skeletal muscle
27	chr6:162621200-162622200	Enhancers	Skeletal Muscle Male	skeletal muscle
28	chr6:162621600-162622000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
29	chr6:162621600-162622400	Enhancers	Fetal Stomach	stomach
30	chr6:162621800-162622200	Enhancers	Fetal Kidney	kidney
31	chr6:162621800-162623000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
32	chr6:162621800-162623000	Enhancers	Fetal Heart	heart
33	chr6:162622000-162622200	Enhancers	Right Ventricle	heart
34	chr6:162622000-162622400	Enhancers	HUES64 Cell Line	embryonic stem cell
35	chr6:162622000-162622400	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
36	chr6:162622000-162622400	Enhancers	Cortex derived primary cultured neurospheres	brain
37	chr6:162622000-162622400	Enhancers	Fetal Brain Male	brain
38	chr6:162622000-162622400	Enhancers	Left Ventricle	heart
39	chr6:162622000-162622400	Enhancers	Rectal Smooth Muscle	rectum
40	chr6:162622000-162622400	Enhancers	Right Atrium	heart
41	chr6:162622000-162622400	Active TSS	Stomach Smooth Muscle	stomach
42	chr6:162622000-162622600	Enhancers	iPS-18 Cell Line	embryonic stem cell
43	chr6:162622000-162623000	Enhancers	Colon Smooth Muscle	Colon
44	chr6:162622200-162622800	Weak transcription	Skeletal Muscle Male	skeletal muscle
45	chr6:162622400-162622600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
46	chr6:162622400-162622800	Enhancers	Psoas Muscle	Psoas
47	chr6:162622400-162624200	Weak transcription	Cortex derived primary cultured neurospheres	brain
48	chr6:162622400-162624400	Weak transcription	Aorta	Aorta
49	chr6:162622400-162624400	Weak transcription	Fetal Stomach	stomach
50	chr6:162622400-162632000	Weak transcription	Left Ventricle	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links